Scientists engineer a virus known to be be harmless to humans to stimulate an immune response against the coronavirus family in mice.

Scientists engineer a virus known to be be harmless to humans to stimulate an immune response against the coronavirus family in mice.
A blackboard of therapeutic innovation: Researchers seek to understand how antisense oligonucleotides can “erase” disorders.
The Lahann Lab at the University of Michigan discusses how nanomedicine benefits by bridging biology, engineering, and materials.
A team of researchers overcomes antibiotic resistance in MRSA by combining antibiotics with irradiation.
A new case study monitors the evolution of testing guidelines in the face of a growing global pandemic.
Potential vaccine against COVID-19 could begin human trials after FDA approval.
Computational modelling enhances the multidisciplinary approach to understanding the epithelial-to-mesenchymal transition in cancer metastasis.
With the current COVID-19 pandemic ongoing, we were curious how Wiley journals were publishing the latest research 100 years ago, when another, and worse, pandemic ravaged the world.
A recent study discovers that CRISPR can be used for a number of different purposes by diverse biological entities, not just humans and bacteria.
A device uses sound waves to detect the stiffness of an extracellular matrix, a structural network that contains cells, which researchers find can indicate the spread of disease.